As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.
Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 26 years since it entered the market, this groundbreaking device has helped more than 450,000 patients recover from heart injuries.
The first-of-its-kind targeted oral peptide therapy for moderate to severe plaque psoriasis has been chosen for the annual list, which recognizes innovations for their originality, ambition and impact.